A Cohort Establishment Study of Total Management of Ovarian Cancer
NCT06018935 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2024-06-20
Summary
A cohort establishment study of total management of ovarian cancer (including fallopian tube cancer and primary peritoneal cancer).
Conditions
- Tumor of Female Reproductive System
- Ovarian Cancer
Interventions
- OTHER
-
No intervention
No intervention
Sponsors & Collaborators
-
Sichuan Cancer Hospital and Research Institute
lead OTHER
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-06-17
- Primary Completion
- 2025-09-01
- Completion
- 2025-09-01
Countries
- China
Study Locations
More Related Trials
-
Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test
NCT06366997 ·Status: COMPLETED
-
Surgery for Relapsed Ovarian Cancer in Precision
NCT06602063 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Exploring Gut Microbiome Differences in Female Cancer Patients With Varied Ovarian Function and Fertility Outcomes Following Immune Checkpoint Inhibitor Therapy
NCT07201259 ·Status: NOT_YET_RECRUITING
-
Survival Outcomes of Ovarian Malignancies in Chinese Population
NCT03291262 ·Status: UNKNOWN
-
Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer
NCT05236686 ·Status: RECRUITING ·Phase: NA
-
Treatment for Malignant Ovarian Cancer: Laparoscopy vs Laparotomy
NCT02686463 ·Status: UNKNOWN ·Phase: NA
-
SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer
NCT06055348 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary
NCT06279104 ·Status: RECRUITING
-
Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?
NCT01611766 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of IBI354 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT06834672 ·Status: RECRUITING ·Phase: PHASE3
-
Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer
NCT05737303 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer
NCT03180177 ·Status: UNKNOWN ·Phase: PHASE3
-
Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers
NCT00002538 ·Status: COMPLETED ·Phase: PHASE2
-
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NCT00958698 ·Status: UNKNOWN ·Phase: NA
-
Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NCT01074411 ·Status: COMPLETED ·Phase: PHASE1
-
The Treatment Preferences of Women Diagnosed With Ovarian Cancer
NCT03367260 ·Status: COMPLETED
-
Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging
NCT06084195 ·Status: RECRUITING ·Phase: NA
-
PARPi and Ovarian Cancer Survival
NCT06838429 ·Status: NOT_YET_RECRUITING
-
A Pilot Test for Newly Developed Synoptic Operative Template for Ovarian Cancer (SOTOC): National Cancer Center - Peritoneal Carcinomatosis Index
NCT01823731 ·Status: UNKNOWN
-
Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer
NCT05633199 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT00719303 ·Status: UNKNOWN ·Phase: PHASE3
-
Debulking Surgery in Ovarian Cancer
NCT03378128 ·Status: COMPLETED ·Phase: NA
-
Individualized Health Management of Epithelial Ovarian Cancer: A Retrospective Study
NCT06085456 ·Status: RECRUITING
-
Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer
NCT06907771 ·Status: RECRUITING
-
Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery
NCT03373058 ·Status: UNKNOWN ·Phase: PHASE3